Cargando…
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
BACKGROUND: Gastrointestinal manifestations of coronavirus disease 2019 (COVID-19) appear to be substantial. Fecal calprotectin is a promising biomarker in COVID-19 associated gastrointestinal inflammation; however, its role in the severity of COVID-19 remains limited. We conducted a study to analyz...
Autores principales: | Adriana, Deasy Natalia, Sugihartono, Titong, Nusi, Iswan Abbas, Setiawan, Poernomo Boedi, Purbayu, Herry, Maimunah, Ummi, Kholili, Ulfa, Widodo, Budi, Thamrin, Husin, Vidyani, Amie, Maulahela, Hasan, Yamaoka, Yoshio, Miftahussurur, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360717/ https://www.ncbi.nlm.nih.gov/pubmed/35945626 http://dx.doi.org/10.1186/s13099-022-00507-y |
Ejemplares similares
-
High levels of fecal calprotectin and C-reactive protein in patients with colitis
por: Anindita, Brinna, et al.
Publicado: (2023) -
Diagnostic Value of (14)C Urea Breath Test for Helicobacter pylori Detection Compared by Histopathology in Indonesian Dyspeptic Patients
por: Miftahussurur, Muhammad, et al.
Publicado: (2021) -
Association between host TNF-α, TGF-β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients
por: Wungu, Citrawati Dyah Kencono, et al.
Publicado: (2019) -
Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia
por: Miftahussurur, Muhammad, et al.
Publicado: (2017) -
Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia
por: Miftahussurur, Muhammad, et al.
Publicado: (2022)